GPT Healthcare Ltd (GPTHEALTH) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company reported a 12.5% year-on-year growth in revenue, reaching INR 118.9 crores, demonstrating steady top-line expansion despite a seasonally muted quarter.
- EBITDA performance was impacted by initial operational losses of approximately INR 4.5 crores from the newly commissioned Raipur hospital, leading to a 10% YoY decline in EBITDA to INR 24.1 crores.
- The company is advancing its expansion strategy to become a 1000-bed hospital chain, highlighted by the signing of a new 150-bed hospital in Jamshedpur with a planned investment of INR 70 crores.
- Operational efficiency improved, with the average length of stay (ALOS) reducing to 3.49 days, reflecting a strategic shift in case mix towards shorter-stay departments.
- Existing mature hospitals demonstrated robust performance, with significant growth in Average Revenue Per Occupied Bed (ARPOB) and occupancy rates, particularly at the Salt Lake and Agartala units.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.